Reckitt Benckiser Group (LON:RKT – Get Free Report) announced its quarterly earnings results on Friday. The company reported GBX 147.08 earnings per share for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a net margin of 22.40% and a return on equity of 45.27%.
Reckitt Benckiser Group Stock Performance
Shares of LON RKT traded up GBX 21 during mid-day trading on Friday, reaching GBX 5,018. 1,970,654 shares of the company’s stock were exchanged, compared to its average volume of 25,951,900. The firm has a 50-day moving average price of GBX 4,714.32 and a two-hundred day moving average price of GBX 5,376.02. The company has a debt-to-equity ratio of 108.83, a current ratio of 0.85 and a quick ratio of 0.46. The firm has a market capitalization of £31.87 billion, a price-to-earnings ratio of 10.31, a price-to-earnings-growth ratio of 1.10 and a beta of 0.25. Reckitt Benckiser Group has a 52 week low of GBX 3,866 and a 52 week high of GBX 6,522.92.
Insider Activity at Reckitt Benckiser Group
In related news, insider Marybeth Hays acquired 340 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was acquired at an average price of GBX 4,585 per share, for a total transaction of £15,589. Also, insider Deepak Nath purchased 257 shares of the firm’s stock in a transaction dated Tuesday, June 23rd. The shares were bought at an average price of GBX 4,650 per share, with a total value of £11,950.50. Insiders have purchased a total of 1,029 shares of company stock worth $21,416,350 in the last ninety days. Corporate insiders own 0.44% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Stock Report on Reckitt Benckiser Group
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
